The abnormal expression of CK-19 is associated with different kinds of cancers, including breast cancer, hepatocellular carcinoma, gallbladder cancer andpapillary thyroid carcinoma, by interaction with other biomarkers. The gene discussed is KRT19; the disease is thyroid gland carcinoma.